首页
>
>
投稿咨询
微信添加科研助理

了解相关问题

加急服务
微信添加科研助理

了解相关问题

CANCER CELL
ISSN：1535-6108

CANCER CELL

CANCER CELL
学科领域：医学
是否预警：不在预警名单内
是否OA：否
录用周期：偏慢,4-8周
新锐分区：医学1区
年发文量：112
影响因子：44.5
JCR分区：Q1

基本信息

癌细胞提供了一个高姿态的论坛，以促进癌症研究和肿瘤学的重大进展。考虑稿件的主要标准是研究是否在回答与自然发生的癌症相关的重要问题方面提供了重大进展。Cancer Cell特别欢迎转化研究。《癌细胞》杂志也有兴趣发表临床研究，特别是那些导致建立癌症治疗、诊断或预防新模式的研究;提供超出临床前研究所揭示的对癌症生物学的重要见解的那些;和基于机理的原理验证临床研究。
1535-6108SCIE/Scopus收录
44.5
点击查看最新影响趋势>
53.2
新
2026年3月发布
点击查看历史分区趋势    >
大类学科小类学科Top期刊综述期刊
医学1区
ONCOLOGY 肿瘤学
1区
CELL BIOLOGY 细胞生物学
1区
是
N/A
新
WOS期刊SCI分区  2024-2025最新升级版
按JIF指标学科分区收集子录JIF分区JIF排名百分位
学科：CELL BIOLOGY
SCIE
Q1
4/204
学科：ONCOLOGY
SCIE
Q1
5/328
按JCR指标学科分区收集子录JCR分区JCR排名百分位
学科：CELL BIOLOGY
SCIE
Q1
2/204
学科：ONCOLOGY
SCIE
Q1
6/328
295
112
点击查看年发文量趋势图>
7%极难偏慢,4-8周-医学-肿瘤学
1.3%
点击查看自引率趋势图>
时间预警情况
2026年03月发布的新锐学术版不在预警名单中
2025年03月发布的2025版不在预警名单中
2024年02月发布的2024版不在预警名单中
2023年01月发布的2023版不在预警名单中
2021年12月发布的2021版不在预警名单中
2020年12月发布的2020版不在预警名单中
93.75%31.56%7.29%
CiteScore：57.70
SJR：19.027
SNIP：5.728
学科类别分区排名百分位
大类：Medicine
小类：Oncology
Q1
6 / 415
大类：Medicine
小类：Cancer Research
Q1
4 / 233

期刊高被引文献

Targeting Ferroptosis to Iron Out Cancer.
来源期刊：Cancer cellDOI：10.1016/j.ccell.2019.04.002
Genomic and Transcriptomic Landscape of Triple-Negative Breast Cancers: Subtypes and Treatment Strategies.
来源期刊：Cancer cellDOI：10.1016/j.ccell.2019.02.001
Gain Fat-Lose Metastasis: Converting Invasive Breast Cancer Cells into Adipocytes Inhibits Cancer Metastasis.
来源期刊：Cancer cellDOI：10.1016/j.ccell.2018.12.002
Antitumor Responses in the Absence of Toxicity in Solid Tumors by Targeting B7-H3 via Chimeric Antigen Receptor T Cells.
来源期刊：Cancer cellDOI：10.1016/j.ccell.2019.01.002
Histone H3.3 K27M Accelerates Spontaneous Brainstem Glioma and Drives Restricted Changes in Bivalent Gene Expression.
来源期刊：Cancer cellDOI：10.1016/j.ccell.2018.11.015
Targeting an RNA-Binding Protein Network in Acute Myeloid Leukemia.
来源期刊：Cancer cellDOI：10.1016/j.ccell.2019.01.010
A Platform of Synthetic Lethal Gene Interaction Networks Reveals that the GNAQ Uveal Melanoma Oncogene Controls the Hippo Pathway through FAK.
来源期刊：Cancer cellDOI：10.1016/j.ccell.2019.01.009
Glycosylation in the Era of Cancer-Targeted Therapy: Where Are We Heading?
来源期刊：Cancer cellDOI：10.1016/j.ccell.2019.06.006
Epithelial NOTCH Signaling Rewires the Tumor Microenvironment of Colorectal Cancer to Drive Poor-Prognosis Subtypes and Metastasis
来源期刊：Cancer CellDOI：10.1016/j.ccell.2019.08.003
Proteogenomic Characterization of Human Early-Onset Gastric Cancer.
来源期刊：Cancer cellDOI：10.1016/j.ccell.2018.12.003
Combination of Hypoglycemia and Metformin Impairs Tumor Metabolic Plasticity and Growth by Modulating the PP2A-GSK3β-MCL-1 Axis.
来源期刊：Cancer cellDOI：10.1016/j.ccell.2019.03.007
Pangenomic Classification of Pituitary Neuroendocrine Tumors.
来源期刊：Cancer cellDOI：10.1016/j.ccell.2019.11.002
Mubritinib Targets the Electron Transport Chain Complex I and Reveals the Landscape of OXPHOS Dependency in Acute Myeloid Leukemia.
来源期刊：Cancer cellDOI：10.1016/j.ccell.2019.06.003
Toward the Early Detection of Cancer by Decoding the Epigenetic and Environmental Fingerprints of Cell-Free DNA.
来源期刊：Cancer cellDOI：10.1016/j.ccell.2019.09.003
Small-Molecule MYC Inhibitors Suppress Tumor Growth and Enhance Immunotherapy.
来源期刊：Cancer cellDOI：10.1016/j.ccell.2019.10.001
The Polycomb Repressor Complex 1 Drives Double-Negative Prostate Cancer Metastasis by Coordinating Stemness and Immune Suppression.
来源期刊：Cancer cellDOI：10.1016/j.ccell.2019.06.009
Clonally Expanded T Cells Reveal Immunogenicity of Rhabdoid Tumors.
来源期刊：Cancer cellDOI：10.1016/j.ccell.2019.10.008
HOTTIP lncRNA Promotes Hematopoietic Stem Cell Self-Renewal Leading to AML-like Disease in Mice
来源期刊：Cancer cellDOI：10.1016/j.ccell.2019.10.011
Targeting TMEM176B Enhances Antitumor Immunity and Augments the Efficacy of Immune Checkpoint Blockers by Unleashing Inflammasome Activation
来源期刊：Cancer CellDOI：10.1016/j.ccell.2019.04.003
Complete Regression of Advanced Pancreatic Ductal Adenocarcinomas upon Combined Inhibition of EGFR and C-RAF.
来源期刊：Cancer cellDOI：10.1016/j.ccell.2019.03.002
p53 Is a Master Regulator of Proteostasis in SMARCB1-Deficient Malignant Rhabdoid Tumors.
来源期刊：Cancer cellDOI：10.1016/j.ccell.2019.01.006
Pan-cancer Convergence to a Small-Cell Neuroendocrine Phenotype that Shares Susceptibilities with Hematological Malignancies.
来源期刊：Cancer cellDOI：10.1016/j.ccell.2019.06.005
p62/SQSTM1 Fuels Melanoma Progression by Opposing mRNA Decay of a Selective Set of Pro-metastatic Factors.
来源期刊：Cancer cellDOI：10.1016/j.ccell.2018.11.008
The ERBB-STAT3 Axis Drives Tasmanian Devil Facial Tumor Disease
来源期刊：Cancer CellDOI：10.1016/j.ccell.2018.11.018
Paradigms for Precision Medicine in Epichaperome Cancer Therapy.
来源期刊：Cancer cellDOI：10.1016/j.ccell.2019.09.007
LMO2 Confers Synthetic Lethality to PARP Inhibition in DLBCL.
来源期刊：Cancer cellDOI：10.1016/j.ccell.2019.07.007
Protein Kinase Cι and Wnt/β-Catenin Signaling: Alternative Pathways to Kras/Trp53-Driven Lung Adenocarcinoma.
来源期刊：Cancer cellDOI：10.1016/j.ccell.2019.07.002
Passenger Hotspot Mutations in Cancer.
来源期刊：Cancer cellDOI：10.1016/j.ccell.2019.08.002
Hijacking EMT: Better Fat Than Dead.
来源期刊：Cancer cellDOI：10.1016/j.ccell.2018.12.007
Oncogenic KRAS Drives Immune Suppression in Colorectal Cancer.
来源期刊：Cancer cellDOI：10.1016/j.ccell.2019.03.008
γ-Catenin-Dependent Signals Maintain BCR-ABL1+ B Cell Acute Lymphoblastic Leukemia.
来源期刊：Cancer cellDOI：10.1016/j.ccell.2019.03.005
Colon Cancer: Epithelial Notch Signaling Recruits Neutrophils to Drive Metastasis.
来源期刊：Cancer cellDOI：10.1016/j.ccell.2019.08.010
Recruit or Reboot? How Does Anti-PD-1 Therapy Change Tumor-Infiltrating Lymphocytes?
来源期刊：Cancer cellDOI：10.1016/j.ccell.2019.08.009
The Stromal and Immune Landscape of Colorectal Cancer Progression during Anti-EGFR Therapy.
来源期刊：Cancer cellDOI：10.1016/j.ccell.2019.06.001
Acquired Resistance Is Oncogene and Drug Agnostic.
来源期刊：Cancer cellDOI：10.1016/j.ccell.2019.09.011
Venetoclax in Lymphoid Malignancies: New Insights, More to Learn.
来源期刊：Cancer cellDOI：10.1016/j.ccell.2019.09.008
Doomed from the TERT? A Two-Stage Model of Tumorigenesis in IDH-Wild-Type Glioblastoma.
来源期刊：Cancer cellDOI：10.1016/j.ccell.2019.03.009
The Direct Molecular Target for Imipridone ONC201 Is Finally Established.
来源期刊：Cancer cellDOI：10.1016/j.ccell.2019.04.010
M-TAP Dance: Targeting PRMT1 and PRMT5 Family Members to Push Cancer Cells Over the Edge.
来源期刊：Cancer cellDOI：10.1016/j.ccell.2019.06.004
Fatty Acids Corrupt Neutrophils in Cancer.
来源期刊：Cancer cellDOI：10.1016/j.ccell.2019.05.007
The Origin of CIMP, At Last.
来源期刊：Cancer cellDOI：10.1016/j.ccell.2019.01.015
A Positive Step toward Understanding Double-Negative Metastatic Prostate Cancer.
来源期刊：Cancer cellDOI：10.1016/j.ccell.2019.07.006
Overcoming Treatment Toxicity through Sequential Therapy.
来源期刊：Cancer cellDOI：10.1016/j.ccell.2019.05.006
Companion Diagnostics to Identify Biomarkers of Response to Anticancer Drugs Targeting the Proteome.
来源期刊：Cancer cellDOI：10.1016/j.ccell.2019.10.003
Teaching an Old Drug New Tricks.
来源期刊：Cancer cellDOI：10.1016/j.ccell.2019.04.008
Thrown for a Loop: Awakening BORIS to Evade ALK Inhibition Therapy.
来源期刊：Cancer cellDOI：10.1016/j.ccell.2019.09.009
LMO2 as a Biomarker for Hypersensitivity to Genotoxic Therapy.
来源期刊：Cancer cellDOI：10.1016/j.ccell.2019.08.011
PRC2 Plays Red Light, Green Light with MHC-I and CD8+ T Cells.
来源期刊：Cancer cellDOI：10.1016/j.ccell.2019.09.010
Tails of a Super Histone.
来源期刊：Cancer cellDOI：10.1016/j.ccell.2018.12.005
Stressing Out about Cancer Immunotherapy.
来源期刊：Cancer cellDOI：10.1016/j.ccell.2019.10.013

相关文章

CANCER CELL癌症研究领域， 一直处于领先地位！对中国作者友好，审稿周期短,难度高！
2025-08-06
Materials Today Bio解析：IF=8.7，8天初审
2025-11-25
《ZEITSCHRIFT FUR GEBURTSHILFE UND NEONATOLOGIE》德国老牌产科期刊免版面费、非预警，毕业保底首选！
2025-11-25
Journal of Multidisciplinary Healthcare：IF= 2.4，中科院3区，JCR Q2，多学科综合医学开放获取期刊，应用性强，审稿迅速，编辑反馈专业！
2025-10-15
European Journal of Medical Genetics：IF= 1.7，中科院4区，JCR Q3，医学遗传学期刊，涵盖分子遗传学、临床基因诊断与罕见病研究，欧洲地区影响力较稳，国际传播适中！
2025-10-15
ANNALS OF ONCOLOGY：中科院1区，肿瘤学，接受率为25%
2025-10-15
Journal of Cystic Fibrosis：权威官方背景，高影响力，整体周期约 3 个月，部分 1 天录用
2025-10-15
JOURNAL OF INHERITED METABOLIC DISEASE：影响因子平稳，学术认可度高，年发文稳定，4个月录用
2025-10-15
JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL HYGIENE：自引风险小，审稿周期短，发表难度低，但if持续下降
2025-10-15
Neurobiology of Stress：中科院 2 区，认可度高，国人发文第二，机会公平
2025-10-15

期刊推荐

Acta Biomaterialia封面

Acta Biomaterialia

学科领域：医学
影响因子：9.6
中科院分区： 1区
ACTA PHARMACOLOGICA SINICA封面

ACTA PHARMACOLOGICA SINICA

学科领域：医学
影响因子：8.4
中科院分区： 1区
ADVANCED DRUG DELIVERY REVIEWS封面

ADVANCED DRUG DELIVERY REVIEWS

学科领域：医学
影响因子：17.6
中科院分区： 1区
AGEING RESEARCH REVIEWS封面

AGEING RESEARCH REVIEWS

学科领域：医学
影响因子：12.4
中科院分区： 1区
论文发表 2-4个月录用 7500+文章录用 不成功可退款
新
2026年3月发布（新锐分区）
大类学科小类学科Top期刊综述期刊
医学1区
ONCOLOGY 肿瘤学
1区
CELL BIOLOGY 细胞生物学
1区
是
N/A
2025年3月升级版
大类学科小类学科Top期刊综述期刊
医学1区
CELL BIOLOGY 细胞生物学
1区
ONCOLOGY 肿瘤学
1区
是
否
2023年12月旧的升级版
大类学科小类学科Top期刊综述期刊
医学1区
CELL BIOLOGY 细胞生物学
1区
ONCOLOGY 肿瘤学
1区
是
否